Overview

DNA Sequencing Market is poised to register a CAGR of 11.4% during the forecast period 2022 to 2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of DNA Sequencing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the DNA Sequencing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business Application.

Major players included in the DNA Sequencing Market:
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Qiagen
• F. Hoffmann-La Roche Ltd.
• Oxford Nanopore Technologies Ltd.
• Macrogen, Inc.
• Perkin Elmer, Inc.
• Pacific Biosciences of California, Inc.
• BGI
• Bio-Rad Laboratories, Inc.
• Myriad Genetics
• PierianDx
• Intrexon Bioinformatics Germany GmbH
• Eurofins Scientific
(Note: The list of the major players will be updated with the latest market scenario and trends)

DNA Sequencing Market Segmentation:
By Product & Services
• Consumables
• Instruments
• Services

By Technology
• Sanger Sequencing
• Next-Generation Sequencing
 o Whole Genome Sequencing (WGS)
 o Whole Exome Sequencing (WES)
 o Targeted Sequencing & Resequencing
• Third Generation DNA Sequencing  
 o Single-Molecule Real-Time Sequencing (SMRT)
 o Nanopore Sequencing

By Workflow
• Pre-sequencing
• Sequencing
• Data Analysis

By Application
• Oncology
• Reproductive Health
• Clinical Investigation
• Agrigenomics & Forensics
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Consumer Genomics
• Others

By End-use
• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other Users

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the DNA Sequencing Market By Product & Services, By Technology, By Workflow, By Application, By End-use and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Product & Services launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Technologyology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. DNA Sequencing Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of DNA Sequencing Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. DNA Sequencing Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. DNA Sequencing Market, By Product & Services Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Consumables
  7.2. Instruments
  7.3. Services

8. DNA Sequencing Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million)  
  8.1. Sanger Sequencing
  8.2. Next-Generation Sequencing
       8.2.1. Whole Genome Sequencing (WGS)
8.2.2. Whole Exome Sequencing (WES)
8.2.3. Targeted Sequencing & Resequencing
  8.3. Third Generation DNA Sequencing  
       8.3.1. Single-Molecule Real-Time Sequencing (SMRT)
       8.3.2. Nanopore Sequencing
       
9. DNA Sequencing Market, By Workflow Historical Analysis and Forecast 2022-2028 (USD Million)  
  9.1. Pre-sequencing
  9.2. Sequencing
  9.3. Data Analysis
     
10. DNA Sequencing Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)  
   10.1. Oncology
   10.2. Reproductive Health
   10.3. Clinical Investigation
   10.4. Agrigenomics & Forensics
   10.5. HLA Typing/Immune System Monitoring
   10.6. Metagenomics, Epidemiology & Drug Development
   10.7. Consumer Genomics
   10.8. Others

11. DNA Sequencing Market, By End-use Historical Analysis and Forecast 2022-2028 (USD Million)  
   11.1. Academic Research
   11.2. Clinical Research
   11.3. Hospitals & Clinics
   11.4. Pharmaceutical & Biotechnology Companies
   11.5. Other Users

12. North America DNA Sequencing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
  12.1. Introduction
  12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
       12.2.1. U.S.A
       12.2.2. Canada
       12.2.3. Mexico
  12.3. Market Size (USD Million) Forecast for North America 2022-2028

13. Latin America DNA Sequencing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         13.2.1. Brazil
         13.2.2. Venezuela
         13.2.3. Argentina
         13.2.4. Rest of Latin America
   13.3. Market Size (USD Million) Forecast for Latin America 2022-2028

14. Europe DNA Sequencing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         14.2.1. Germany
         14.2.2. U.K        
         14.2.3. France
         14.2.4. Italy
         14.2.5. Spain
         14.2.6. Russia
         14.2.7. Poland
         14.2.8. Rest of Europe
   14.3. Market Size (USD Million) Forecast for Europe 2022-2028

15. Asia Pacific DNA Sequencing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         15.2.1. Japan
         15.2.2. China
         15.2.3. India
         15.2.4. Australia and New Zealand
         15.2.5. ASEAN
         15.2.6. Rest of Asia Pacific
   15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

16. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   16.1. Introduction
   16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         16.2.1. GCC
         16.2.2. Israel
         16.2.3. South Africa
         16.2.4. Rest of MEA
   16.3. Market Size (USD Million) Forecast for MEA 2022-2028

17. Market Share Analysis and Competitive Landscape  
   17.1. Global Landscape - Key Players, Revenue and Presence
   17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   17.3. Global Emerging Companies
   17.4.  North America - Market Share Analysis and Key Regional Players
   17.5.  Europe - Market Share Analysis and Key Regional Players
   17.6.  Asia Pacific - Market Share Analysis and Key Regional Players
   17.7.  Global Key Player - Growth Matrix

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product & Servicess Offered and Financial Layouts)
   18.1. Agilent Technologies, Inc.
         18.1.1. Company Overview
         18.1.2. Product Portfolio
         18.1.3. SWOT Analysis
         18.1.4. Financial Overview
         18.1.5. Strategic Overview
   18.2. Thermo Fisher Scientific, Inc.
         18.2.1. Company Overview
         18.2.2. Product Portfolio
         18.2.3. SWOT Analysis
         18.2.4. Financial Overview
         18.2.5. Strategic Overview
   18.3. Illumina, Inc.
         18.3.1. Company Overview
         18.3.2. Product Portfolio
         18.3.3. SWOT Analysis
         18.3.4. Financial Overview
         18.3.5. Strategic Overview
   18.4. Qiagen
         18.4.1. Company Overview
         18.4.2. Product Portfolio
         18.4.3. SWOT Analysis
         18.4.4. Financial Overview
         18.4.5. Strategic Overview
   18.5. F. Hoffmann-La Roche Ltd.
         18.5.1. Company Overview
         18.5.2. Product Portfolio
         18.5.3. SWOT Analysis
         18.5.4. Financial Overview
         18.5.5. Strategic Overview          
   18.6. Oxford Nanopore Technologies Ltd.
         18.6.1. Company Overview
         18.6.2. Product Portfolio
         18.6.3. SWOT Analysis
         18.6.4. Financial Overview
         18.6.5. Strategic Overview      
   18.7. Macrogen, Inc.
         18.7.1. Company Overview
         18.7.2. Product Portfolio
         18.7.3. SWOT Analysis
         18.7.4. Financial Overview
         18.7.5. Strategic Overview
   18.8. Perkin Elmer, Inc.
         18.8.1. Company Overview
         18.8.2. Product Portfolio
         18.8.3. SWOT Analysis
         18.8.4. Financial Overview
         18.8.5. Strategic Overview
   18.9. Pacific Biosciences of California, Inc.
         18.9.1. Company Overview
         18.9.2. Product Portfolio
         18.9.3. SWOT Analysis
         18.9.4. Financial Overview
         18.9.5. Strategic Overview
   18.10.BGI
         18.10.1. Company Overview
         18.10.2. Product Portfolio
         18.10.3. SWOT Analysis
         18.10.4. Financial Overview
         18.10.5. Strategic Overview
   18.11.Bio-Rad Laboratories, Inc.
         18.11.1. Company Overview
         18.11.2. Product Portfolio
         18.11.3. SWOT Analysis
         18.11.4. Financial Overview
         18.11.5. Strategic Overview
   18.12.Myriad Genetics
         18.12.1. Company Overview
         18.12.2. Product Portfolio
         18.12.3. SWOT Analysis
         18.12.4. Financial Overview
         18.12.5. Strategic Overview
   18.13.PierianDx
         18.13.1. Company Overview
         18.13.2. Product Portfolio
         18.13.3. SWOT Analysis
         18.13.4. Financial Overview
         18.13.5. Strategic Overview
   18.14.Intrexon Bioinformatics Germany GmbH
         18.14.1. Company Overview
         18.14.2. Product Portfolio
         18.14.3. SWOT Analysis
         18.14.4. Financial Overview
         18.14.5. Strategic Overview
   18.15.Eurofins Scientific
         18.15.1. Company Overview
         18.15.2. Product Portfolio
         18.15.3. SWOT Analysis
         18.15.4. Financial Overview
         18.15.5. Strategic Overview
 
19. Pre and Post COVID-19 Impact
   19.1. Positive influence on the healthcare industry
   19.2. The financial disruption of the manufacturing sector
   19.3. Impact of COVID-19 on emerging companies
   19.4. Significant mandates in the healthcare regulations initiated by administrations
   19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME Key Takeaway Points for Client

Tables

Figures